REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

B&N Pharma 1999 Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: B&N PHARMA 1999 Gyogyszereszeti es Kereskedelmi Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

B&N Pharma 1999 Bt. is an enterprise in Hungary, with the main office in Szeged. The company operates in the Pharmacies and Drug Stores sector. The company was established on December 21, 1998. It currently has a total number of 8 (2024) employees. In 2023, the company reported a net sales revenue increase of 11.47%. Its’ total assets recorded a growth of 21.38%. B&N Pharma 1999 Bt.’s net profit margin increased by 0.64% in 2023.

Headquarters
Ortutay u. 4.
Szeged; Csongrad; Postal Code: 6723

Contact Details: Purchase the B&N Pharma 1999 Bt. report to view the information.

Basic Information
Total Employees:
Purchase the B&N Pharma 1999 Bt. report to view the information.
Outstanding Shares:
Purchase the B&N Pharma 1999 Bt. report to view the information.
Registered Capital:
Purchase the B&N Pharma 1999 Bt. report to view the information.
Financial Auditors:
Purchase the B&N Pharma 1999 Bt. report to view the information.
Incorporation Date:
December 21, 1998
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Csanad Pharma Kft.
Company Performance
Financial values in the chart are available after B&N Pharma 1999 Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
11.47%▲
Total operating revenue
12%▲
Operating profit (EBIT)
24.06%▲
EBITDA
19.9%▲
Net Profit (Loss) for the Period
28.77%▲
Total assets
21.38%▲
Total equity
21.73%▲
Operating Profit Margin (ROS)
0.6%▲
Net Profit Margin
0.64%▲
Return on Equity (ROE)
1.42%▲
Quick Ratio
-0.38%▼
Cash Ratio
-0.54%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo